NEK2A expression is regulated by CDK4, which is a major regulator of CA in Her2+ breast cancer cells [62], suggesting that NEK2A may be a downstream target of CDK4, and is involved in CDK4 induced CA. The gene discussed is ERBB2; the disease is breast carcinoma.